Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dipyridamole

Known as: Dipyridamolum, 2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol, Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis- 
A synthetic agent derivative of pyrimido-pyrimidine, with antiplatelet properties. Dipyridamole inhibits adenosine uptake by platelets and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
In this review the usual methods applied in systematic reviews and meta-analyses are outlined. The ideal hypothesis for a… Expand
Highly Cited
2008
Highly Cited
2008
BACKGROUND Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of… Expand
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Review
2007
Review
2007
Context Thirteen new randomized, controlled trials are available since a 1999 meta-analysis of antithrombotic agents for stroke… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND Results of trials of aspirin and dipyridamole combined versus aspirin alone for the secondary prevention of vascular… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Review
2002
Review
2002
Abstract Objective: To determine the effects of antiplatelet therapy among patients at high risk of occlusive vascular events… Expand
Review
2002
Review
2002
OBJECTIVE To determine the effects of antiplatelet therapy among patients at high risk of occlusive vascular events. DESIGN… Expand
Highly Cited
1996
Highly Cited
1996
In 1988, we undertook a randomized, placebo-controlled, double-blind trial to investigate the safety and efficacy of low-dose… Expand
Highly Cited
1988
Highly Cited
1988
To examine the role of antiplatelet therapy in the prevention of arterial restenosis after percutaneous transluminal coronary… Expand
Review
1987
Review
1987
Pentoxifylline (oxpentifylline) is an orally active haemorheological agent for the treatment of peripheral vascular disease… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Highly Cited
1985
Highly Cited
1985
To evaluate the severity of coronary artery disease in patients with severe peripheral vascular disease requiring operation, we… Expand